Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Goeteborg, Sweden Clinical Trials

A listing of Goeteborg, Sweden clinical trials actively recruiting patients volunteers.

RESULTS

Found (3) clinical trials

177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours

This is a phase I study of 177Lu-DOTA-TATE in combination with the PARP-inhibitor olaparib for treatment of patients with somatostatin receptor positive tumours detected by 68Ga-DOTA-TATE/TOC PET. The combination of a PARP inhibitor that will specifically target the repair mechanism, with ionising radiation causing SSB's might overcome the repair dependent …

Phase

0.0 miles

Learn More »

A First-in-human Clinical Evaluation of SN132D in Patients With Breast Cancer

This phase I, first-in-human (FIH) study is open-label, non-randomised and non-placebo-controlled. The study is designed to evaluate the safety, tolerability and pharmacokinetics (PK) of a single intravenous dose of SN132D in up to 20 patients with breast cancer. Magnetic resonance imaging (MRI) will be performed pre- and post-infusion of SN132D.

Phase

0.0 miles

Learn More »

Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers

Obeticholic acid will be administered orally at a dose of 25 mg/day during three weeks to 20 morbidly obese patients awaiting Roux-en-Y gastric bypass and to 20 healthy volunteers. On the days before the first and after the last dose faeces and blood are sampled for the analyses of bile …

Phase

0.0 miles

Learn More »